Novartis: Lower Dose Of Flu Vaccine Sufficient – 1229th Edition

Pharmaceutical maker Novartis AG says a U.S. clinical study suggests that half a dose of its swine flu vaccine may be sufficient to protect people from the virus and could allow many more to be immunized with current supplies.

Tags: ,

Leave a Reply